Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaideep Behari

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Clinical Transplantation|August 22, 2022
Characterization of hepatic steatosis using controlled attenuation parameter and MRI-derived proton density fat fraction in living donor liver transplantationRachel H Zhuang, Allison K Weinstock, Swaytha Ganesh, et al.
The American Journal of Pathology|October 11, 2014
β-catenin links hepatic metabolic zonation with lipid metabolism and diet-induced obesity in miceJaideep Behari, Huanan Li, Shiguang Liu, et al.
Obesity Science & Practice|April 12, 2021
Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver diseaseJaideep Behari, Lisa Graham, Renwei Wang, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver diseaseSrinevas K Reddy, Jennifer L Steel, Hui-Wei Chen, et al.
Clinical Transplantation|May 8, 2021
Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantationQiaochu Qi, Allison K Weinstock, Kalina Chupetlovska, et al.
Hepatology Communications|July 3, 2023
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosisJaideep Behari, Amir Gougol, Renwei Wang, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2026
PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort StudyDaniel Q Huang, Zhongjie Zhang, Rajkumar Dorajoo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2020
Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort StudyHung N Luu, Jaideep Behari, George Boon-Bee Goh, et al.
Cell Reports Methods|April 15, 2025
Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadataMark T Miedel, Mahboubeh Varmazyad, Mengying Xia, et al.
The American Journal of Gastroenterology|August 31, 2016
Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require HospitalizationMichael A Dunn, Deborah A Josbeno, Amit D Tevar, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Clinical Transplantation|August 22, 2022
Characterization of hepatic steatosis using controlled attenuation parameter and MRI-derived proton density fat fraction in living donor liver transplantationRachel H Zhuang, Allison K Weinstock, Swaytha Ganesh, et al.
The American Journal of Pathology|October 11, 2014
β-catenin links hepatic metabolic zonation with lipid metabolism and diet-induced obesity in miceJaideep Behari, Huanan Li, Shiguang Liu, et al.
Obesity Science & Practice|April 12, 2021
Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver diseaseJaideep Behari, Lisa Graham, Renwei Wang, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver diseaseSrinevas K Reddy, Jennifer L Steel, Hui-Wei Chen, et al.
Clinical Transplantation|May 8, 2021
Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantationQiaochu Qi, Allison K Weinstock, Kalina Chupetlovska, et al.
Hepatology Communications|July 3, 2023
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosisJaideep Behari, Amir Gougol, Renwei Wang, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2026
PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort StudyDaniel Q Huang, Zhongjie Zhang, Rajkumar Dorajoo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2020
Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort StudyHung N Luu, Jaideep Behari, George Boon-Bee Goh, et al.
Cell Reports Methods|April 15, 2025
Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadataMark T Miedel, Mahboubeh Varmazyad, Mengying Xia, et al.
The American Journal of Gastroenterology|August 31, 2016
Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require HospitalizationMichael A Dunn, Deborah A Josbeno, Amit D Tevar, et al.
Pageof 9